miércoles, 8 de mayo de 2024

Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00756-9/abstract?utm_campaign=update-laninf&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_laninf&_hsenc=p2ANqtz-_qW4Lt8uN679lNgEQP5_2UQkB2YEmYcIvJG4poCnS8Rf5srJu8OHcmVFKxKLxZmLM87HvBmhKegBqqTmzcNrBVLIDxZA&_hsmi=306008168&utm_content=305979970&utm_source=hs_email

No hay comentarios:

Publicar un comentario